Seth Ettenberg and Nick discuss how technology is used to develop regenerative medicine for conditions such as Parkinson's disease and Alzheimer's disease.
Seth Ettenberg is CEO and President of BlueRock Therapeutics, a wholly owned subsidiary of Bayer. He’s a biotech entrepreneur, on the cutting edge of something called regenerative medicine.
Seth Ettenberg and Nick discuss how technology is used to develop regenerative medicine for conditions such as Parkinson's disease and Alzheimer's disease.
Seth Ettenberg is CEO and President of BlueRock Therapeutics, a wholly owned subsidiary of Bayer. He’s a biotech entrepreneur, on the cutting edge of something called regenerative medicine.